Skip to content
PHP BiotechHope for Life

Advisory Board · Investor · International licensing

Kleber Miranda

Advisory Board Member

Twenty-one countries is a distribution problem

21+

countries of BD work

2009

founded Molkom, Belo Horizonte

2026

launched Molkom Pharma in the USA

Platforms die in the second market, not the first paper

GEN01-AD is only a platform if someone in a second country can in-license it, manufacture it, and sell it. Miranda’s 23 years of pharmaceutical BD — APIs, finished dose, cosmetics, nutraceuticals, the unglamorous middle of the industry — is the map of that second country. He is also an investor, which is a different kind of attention.

Twenty-one countries of pharmaceutical BD

Kleber Miranda brings more than 30 years of pharmaceutical business development and global market strategy to PHP Biotech’s Advisory Board, spanning Brazil, Latin America, the USA, Europe, and Asia.

He is CEO of Molkom, a Belo Horizonte–based firm founded in 2009 that leads business development across pharmaceutical, cosmetic, nutraceutical, and chemical sectors. His career includes senior commercial roles at Sanofi, Aurobindo, and Glenmark. He is a founder and board member of MKM Biotech and launched Molkom Pharma in the USA in 2026.

With 23 years of international business development experience across more than 21 countries, Miranda focuses on licensing, co-development, and commercialization partnerships that a platform company built around PHP53-nb and GEN01-AD will need.

Markets and houses

Where the commercial record lives

Everything below is meant to be checked. Empty categories are omitted rather than padded.

  • Pharmaceutical licensing
  • Latin American and U.S. market entry
  • API and finished-dose business development
  • M&A in life sciences

Affiliations

  • PHP Biotech International Inc. (Advisory Board; investor)
  • Molkom (CEO)
  • MKM Biotech (founder/board)
  • ADEF (Vice President)

Education

  • Law, FDMC
  • MBA, Fundação Getúlio Vargas
  • International Executive MBA, FDC and UBC Sauder School of Business, Vancouver

Credentials

  • Law, FDMC
  • MBA, FGV
  • International Executive MBA, FDC and University of British Columbia Sauder
  • CEO, Molkom
  • Founder/board, MKM Biotech

No peer-reviewed papers or patents are listed for Kleber Miranda. That is intentional. Experience, appointments, and licenses are the E-E-A-T signals on this page — not a fabricated bibliography.